Application Nr Approved Date Route Status External Links
ANDA201408 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Guanfacine Extended-Release Tablets Are Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) As Monotherapy And As Adjunctive Therapy To Stimulant Medications [ See Clinical Studies ( 14 ) ]. Guanfacine Extended-Release Tablets Are Central Alpha 2a -Adrenergic Receptor Agonist Indicated For The Treatment Of Attention Deficit Hyperactivity Disorder (Adhd) As Monotherapy And As Adjunctive Therapy To Stimulant Medications ( 1 , 14 ) .

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Guanfacine GUANFACINE ZINC3872738

Comments